Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded Net Income towards Common Stockholders of $653.6 million in Q3 2026, down 39.6% from $1.08 billion a year earlier and down 40.6% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Vertex Pharmaceuticals' Net Income towards Common Stockholders came in at $3.98 billion as of Sep 30, 2026, up 8.2% year-over-year; for FY2025, it was $3.95 billion.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at -$535.6 million in FY2024, $3.62 billion in FY2023 (+9.0%), $3.32 billion in FY2022 (+41.8%) and $2.34 billion in FY2021 (-13.6%).
- The Q3 2026 figure is the lowest quarterly Net Income towards Common Stockholders since Q1 2025.
- On a year-over-year basis, Net Income towards Common Stockholders rose in four of the last seven quarters, with growth averaging 1.9%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 59.6% in Q1 2026, against a decline of 41.2% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.1 billion (Q2 2026), $1.03 billion (Q1 2026) and $1.19 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 653.60 Mn |
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.19 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 646.30 Mn |
| Dec 31, 2024 | 913.00 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | -3.59 Bn |
| Mar 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 968.80 Mn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 915.70 Mn |
| Mar 31, 2023 | 699.80 Mn |
| Dec 31, 2022 | 818.90 Mn |
| Sep 30, 2022 | 930.50 Mn |
| Jun 30, 2022 | 810.50 Mn |
| Mar 31, 2022 | 762.10 Mn |
| Dec 31, 2021 | 770.10 Mn |
API Access
Vertex Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();